Date post: | 29-Nov-2015 |
Category: |
Documents |
Upload: | chacha-leuntik-campeurnik |
View: | 17 times |
Download: | 1 times |
LEUKEMIALEUKEMIA
Malignancy of hemopoietic system:Malignant transformation a progenitor/precursor of blood cell clone of malignant cell pathologic proliferation (abnormal) & uncontrolled will cause :
- Suppress in marrow bone marrow failure- Infiltration to the other tissues
ETIOLOGYETIOLOGY
The factors that involve:
A. Chromosome disorders gene of cell proliferation regulator damage suppressor gene
B. Oncogene Oncogene activation neoplastic transformation
Certain cause hasn’t known yet
D. Environment factor
1. Radiation 2. Chemical & drugs 3. Virus: HTLV-1 & Epstein Barr
C. Host factor
Chromosome susceptibility genetic damage
malignant transformation
1. Familial 2. Congenital chromosome disorders 3. Congenital immune deficiency
4. Chronic bone marrow dysfunction
CLASSIFICATIONCLASSIFICATION
I. FAB classification (French-American British) morphology
- Treatment approach
- Disease development
- Prognosis determining
1. Acute Lymphoblastic Leukemia (ALL)
L1: small cell, a little cytoplasma, homogen often in child
L2: large cell, the cytoplasma is more wide,
heterogen adult
L3: larger cell, the cytoplasma:
wide-basophilic,
homogen, vacuolization Burkitt
A. ACUTE
LEUKEMIA :
2. Acute Non-Lymphoblastic Leukemia(ANLL)
M1 (AML): myeloblast without maturation
M2 (AML): myeloblast with maturation
M3 (APL): hypergranular promyelocyte
M4 (Acute Myelomonocytic Leukemia): granulocyte & monocyte maturation
promonocyte & monocyte: >20%
B. CHRONIC LEUKEMIA
1. Chronic myelocytic leukemia (CML)2. Chronic lymphocytic leukemia
II. Other classification
A. The number of leukocyte:1. Leukemic leukemia2. Subleukemic leukemia
B. Cell surface markers immunologic
C. Cytochemist PAS, Peroxides, Sudan Black:
- Lymphoblast
- Myeloblast
- Monoblast
E. Enzyme
D. Chromosome Analysis Philadelphia CML
INCIDENSINCIDENS
- 1/100.000 of population
- The frequency of each type:- ALL : > 80%- ANLL : 10%- CML : 2%
- CLL : not found in children.
Immunologic marker (surface markers) ALL:
1. Non-T Non-B ALL : - Common ALL (“cALL” antigen) mostly in children
the best prognosis
- Null ALL
2. Pre-B ALL
3. B-ALL
4. T-ALL
CLINICAL MANIFESTATIONS CLINICAL MANIFESTATIONS
1. Suppress in bone marrow bone marrow failure pancytopenia
2. Extra medullar infiltration
1. Anemia:- common symptom of anemia
- acute onset & progressive
2. Granulocytopenia:- fever- easy to get infection
3. Thrombocytopenia bleeding- spontaneous/ mild trauma - skin, mucous
BONE MARROW FAILURE
When diagnosed: 70% CNS infiltration without any sign
- Often in T cell ALL
- Meningeal syndrome: intra cranial pressure symptom of meningeal signs
- LCS: pleocytosis blast cell
- Source of extramedularry relapse
4. Symptom of CNS infiltration
5. Gonad- Testes: source of extramedularry relapse
6. Ren
7. Gastrointestinal tract- gut infiltration - ulceration, invagination
8. Eye
BLOOD PROFILEBLOOD PROFILE
1. Peripheral Blood:
- Anemia normocytic normochrom
- Thrombocytopenia
- Leukocyte: (>60%),
(20%) and normally (
15%)
- Blast cell leucocytosis
Mieloblast: Auer rod
2. BONE MARROW:
-Hypercellular dominated by blast cell (leukemia cell)
- Suppress of normal hemopoesis decreasing of normal elemen
Examination of bone marrow is important
to distinguish leukemia with:
- Aplastic Anemia- ITP- Leukemoid Reaction
Leukocyte reaction:
hyperleukocytosis with immature cell
- myeloid: infection, pyogen, massive bleeding, TBC, hemolysis.
- lymphoid: pertusis, mononucleosis infectiosa,
TBC
Leukemoid Reaction:
TREATMENTTREATMENT
Goal/treatment principal:
1. Remission & maintenance recovery
2. To overcome symptoms/consequence
disease & drug
STRATEGY:
1. Induction - remission
2. CNS Prophylactic
3. Maintainance of remission: a. consolidation/ intensification b. maintenance & reinduction
4. Bone marrow transplantation
5. Cessation of therapy
For the first aim chemotherapy
1. Complete remission:
- The symptoms disappear
- All element of blood smear: normal & no blast
- Blast in bone marrow < 5%
2. Incomplete remission:
- Clinically look healthy - 2 of 3 element of blood smear normal - Blast in bone marrow 6 - 10%
REMISSION:
- Antimicrobial infection
- blood component anemia, thrombocytopenia,
granulocytopenia
- Hematopoietic Growth Factor:G-CSFGM-CSF
- Improve general condition
TO OVERCOME SYMPTOMS/CONSEQUENCE Supportive:
PROGNOSISPROGNOSIS
- Without treatment:
> 50% death < 6 month
- With adequate treatment: > 60% remission cALL
1. Age: < 1 year and > 10 year
2. Leukocyte: > 50.000/mm3
3. Sex: boy
4. Mediastinal mass
5. CNS leukemia
6. Type of leukemia: ALL cell T, cell B & Pre-B
7. Philadelphia chromosome
Risk Factor for ALL: